Bradshaw, Tracey A <br/><br/>
Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma.  [electronic resource] 

 -  Respiratory medicine  Jan 2008 
 - 143-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0954-6111 
<br/><br/><label>Standard No.: </label>10.1016/j.rmed.2007.07.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Asthmatic Agents--administration & dosage<br/>Asthma--drug therapy<br/>Drug Administration Routes<br/>Epidemiologic Methods<br/>Female<br/>Humans<br/>Magnesium Sulfate--administration & dosage<br/>Male<br/>Middle Aged<br/>Severity of Illness Index<br/>Treatment Outcome